Literature DB >> 27147619

Dissecting the role of ADAM10 as a mediator of Staphylococcus aureus α-toxin action.

Gisela von Hoven1, Amable J Rivas1, Claudia Neukirch1, Stefan Klein1, Christian Hamm1, Qianqian Qin1, Martina Meyenburg1, Sabine Füser1, Paul Saftig2, Nadja Hellmann3, Rolf Postina4, Matthias Husmann5.   

Abstract

Staphylococcus aureus is a leading cause of bacterial infections in humans, including life-threatening diseases such as pneumonia and sepsis. Its small membrane-pore-forming α-toxin is considered an important virulence factor. By destroying cell-cell contacts through cleavage of cadherins, the metalloproteinase ADAM10 (a disintegrin and metalloproteinase 10) critically contributes to α-toxin-dependent pathology of experimental S. aureus infections in mice. Moreover, ADAM10 was proposed to be a receptor for α-toxin. However, it is unclear whether the catalytic activity or specific domains of ADAM10 are involved in mediating binding and/or subsequent cytotoxicity of α-toxin. Also, it is not known how α-toxin triggers ADAM10's enzymatic activity, and whether ADAM10 is invariably required for all α-toxin action on cells. In the present study, we show that efficient cleavage of the ADAM10 substrate epithelial cadherin (E-cadherin) requires supra-cytotoxic concentrations of α-toxin, leading to significant increases in intracellular [Ca(2+)]; the fall in cellular ATP levels, typically following membrane perforation, became observable at far lower concentrations. Surprisingly, ADAM10 was dispensable for α-toxin-dependent xenophagic targeting of S. aureus, whereas a role for α-toxin attack on the plasma membrane was confirmed. The catalytic site of ADAM10, furin cleavage site, cysteine switch and intracellular domain of ADAM10 were not required for α-toxin binding and subsequent cytotoxicity. In contrast, an essential role for the disintegrin domain and the prodomain emerged. Thus, co-expression of the prodomain with prodomain-deficient ADAM10 reconstituted binding of α-toxin and susceptibility of ADAM10-deficient cells. The results of the present study may help to inform structural analyses of α-toxin-ADAM10 interactions and to design novel strategies to counteract S. aureus α-toxin action.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  E-cadherin; Staphylococcus aureus α-toxin; a disintegrin and metalloproteinase 10 (ADAM10); calcium; cytotoxicity; microtubule-associated protein 1A/1B light chain 3 (LC3)

Mesh:

Substances:

Year:  2016        PMID: 27147619     DOI: 10.1042/BCJ20160062

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

Review 1.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

2.  Effects of Antibiotics on α-Toxin Levels during Staphylococcus aureus Culture: Implications for the Protection of Chondrocytes in a Model of Septic Arthritis.

Authors:  Robbie P Miller; Marie E Berlouis; Alan G Hall; A Hamish R W Simpson; Innes D M Smith; Andrew C Hall
Journal:  Cartilage       Date:  2019-02-14       Impact factor: 4.634

3.  Major Determinants of Airway Epithelial Cell Sensitivity to S. aureus Alpha-Toxin: Disposal of Toxin Heptamers by Extracellular Vesicle Formation and Lysosomal Degradation.

Authors:  Nils Möller; Sabine Ziesemer; Christian Hentschker; Uwe Völker; Jan-Peter Hildebrandt
Journal:  Toxins (Basel)       Date:  2021-02-24       Impact factor: 4.546

4.  Sphingomyelin Depletion from Plasma Membranes of Human Airway Epithelial Cells Completely Abrogates the Deleterious Actions of S. aureus Alpha-Toxin.

Authors:  Sabine Ziesemer; Nils Möller; Andreas Nitsch; Christian Müller; Achim G Beule; Jan-Peter Hildebrandt
Journal:  Toxins (Basel)       Date:  2019-02-20       Impact factor: 4.546

5.  Clostridium perfringens Delta-Toxin Damages the Mouse Small Intestine.

Authors:  Soshi Seike; Masaya Takehara; Keiko Kobayashi; Masahiro Nagahama
Journal:  Toxins (Basel)       Date:  2019-04-22       Impact factor: 4.546

6.  Staphylococcus aureus Alpha-Toxin Limits Type 1 While Fostering Type 3 Immune Responses.

Authors:  Agnes Bonifacius; Oliver Goldmann; Stefan Floess; Silva Holtfreter; Philippe A Robert; Maria Nordengrün; Friederike Kruse; Matthias Lochner; Christine S Falk; Ingo Schmitz; Barbara M Bröker; Eva Medina; Jochen Huehn
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

Review 7.  Functional Consequences of Calcium Influx Promoted by Bacterial Pore-Forming Toxins.

Authors:  Stéphanie Bouillot; Emeline Reboud; Philippe Huber
Journal:  Toxins (Basel)       Date:  2018-09-25       Impact factor: 4.546

8.  A Functional Polymorphism-Mediated Disruption of EGR1/ADAM10 Pathway Confers the Risk of Sepsis Progression.

Authors:  Feng Chen; Yan Wang; Wenying Zhang; Yujie Cai; Tian Zhao; Hui Mai; Shoubao Tao; Wenyan Wei; Jia Li; Xiongjin Chen; Xiaohui Li; Pei Tang; Weihao Fan; Jingqi Yang; Mingqian Ou; Furong Lu; Zhipeng Lai; Huiyi Chen; Ting Zou; Furong Sun; Yiming Shao; Lili Cui
Journal:  mBio       Date:  2019-08-06       Impact factor: 7.867

9.  Mitochondrial Targeting of the Enteropathogenic Escherichia coli Map Triggers Calcium Mobilization, ADAM10-MAP Kinase Signaling, and Host Cell Apoptosis.

Authors:  Rachana Pattani Ramachandran; Chaya Spiegel; Yael Keren; Tsafi Danieli; Naomi Melamed-Book; Ritesh Ranjan Pal; Efrat Zlotkin-Rivkin; Ilan Rosenshine; Benjamin Aroeti
Journal:  mBio       Date:  2020-09-15       Impact factor: 7.867

Review 10.  Diversity and pathogenesis of Staphylococcus aureus from bovine mastitis: current understanding and future perspectives.

Authors:  Bruno Campos; Amy C Pickering; Lis Souza Rocha; Ananda Pereira Aguilar; Mary Hellen Fabres-Klein; Tiago Antônio de Oliveira Mendes; J Ross Fitzgerald; Andrea de Oliveira Barros Ribon
Journal:  BMC Vet Res       Date:  2022-03-24       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.